عنوان
پدید آورنده
موضوع
رده
RC271.R3 C66 2008eb
RC271
.
R3
C66
2008eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
1933864346
(Number (ISBN
1935281003
(Number (ISBN
9781933864341
(Number (ISBN
9781935281009
NATIONAL BIBLIOGRAPHY NUMBER
Number
b779487
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Combining targeted biological agents with radiotherapy :
General Material Designation
[Book]
Other Title Information
current status and future directions /
First Statement of Responsibility
edited by William Small, Jr.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Demos Medical Pub.,
Date of Publication, Distribution, etc.
©2008.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xiv, 226 pages) :
Other Physical Details
illustrations
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Dermatologic manifestations of targeted therapies / Mario E. Lacouture, Bharat B. Mittal, and Mark Agulnik -- Radiolabeled monoclonal antibody therapies / Lanea M.M. Keller [and others] -- Targeted therapies in malignant gliomas / Sean Grimm -- Targeted therapies in head and neck cancer / Ranee Mehra, Roger B. Cohen, and Paul M. Harari.
Text of Note
Targeted therapies in lung cancer / Gregory M.M. Videtic -- Targeted therapies in pancreatic cancer / Sunil Krishnan, Vishal Rana, and Christopher H. Crane -- Targeted therapies in cervical cancer / Christopher J. Anker and David K. Gaffney -- Targeted therapies in endometrial cancer / Jergin Chen and David K. Gaffney.
Text of Note
Targeted therapies: definitions, limitations, and future directions / Tamara Z .Vern and William Small Jr. -- Epidermal growth factor receptors (EGFR) / Michael P. Hagan [and others] -- Vascular epithelial growth factor (VEGF) receptors / Andrew N. Fontanella, Yiting Cao, and Mark W. Dewhirst.
0
0
0
SUMMARY OR ABSTRACT
Text of Note
Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists. Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy w.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Rittenhouse
Stock Number
1933864346
OTHER EDITION IN ANOTHER MEDIUM
Title
Combining targeted biological agents with radiotherapy.
International Standard Book Number
1933864346
TOPICAL NAME USED AS SUBJECT
Cancer-- Radiotherapy.
Combined modality therapy.
Growth factors-- Receptors.
Antineoplastic Agents-- therapeutic use.
Neoplasms-- therapy.
Radiotherapy-- methods.
Cancer-- Radiotherapy.
Combined modality therapy.
Growth factors-- Receptors.
HEALTH & FITNESS-- Diseases-- Cancer.
MEDICAL-- Oncology.
(SUBJECT CATEGORY (Provisional
HEA-- 039030
MED-- 062000
DEWEY DECIMAL CLASSIFICATION
Number
616
.
99/40642
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC271
.
R3
Book number
C66
2008eb
OTHER CLASS NUMBERS
Class number
2008
J-234
Class number
QZ
266
Book Number
C7315
2008
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Small, William,Jr.
ORIGINATING SOURCE
Date of Transaction
20201206183502.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
